KRYS
Krystal Biotech, Inc.$336.17-2.58 (-0.76%)Prev Close$338.75·MCap$10.23B·P/E44.94·Vol122.5K·Yield—
▲
Buys (12M)
0
$0.00
▼
Sells (12M)
15
$94.18M
◆
Net Activity
Net Seller
$94.18M
●
Active Insiders
6
last 12 mo
Over the past 12 months, insider activity at Krystal Biotech, Inc. (KRYS) has been exclusively selling, with 0 insider purchases totaling $0.00 and 15 insider sales totaling $94.18M. The most recent insider transaction was by Krishnan Suma (director, 10 percent owner, officer: President, R&D), who sold $8.98M worth of shares on Sep 4, 2026. Krystal Biotech, Inc. operates in the Healthcare sector, within the Biotechnology industry, with a market cap of $10.23B.
KRYS Insider Trading Activity
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Sep 4, 2026 | Krishnan Suma | director, 10 percent owner, officer: President, R&D | Sell | 25,000 | $359.32 | $8.98M | 1,326,625 |
| Sep 4, 2026 | Krishnan Krish S | director, 10 percent owner, officer: President and CEO | Sell | 25,000 | $359.32 | $8.98M | 1,372,023 |
| Aug 14, 2026 | ROSSI DINO A | director | Sell | 25,000 | $329.12 | $8.23M | 74,659-25% |
| Jun 26, 2026 | Thomas John Charles | officer: EVP, General Counsel | Sell | 1,000 | $347.27 | $347.3K | 0Exit |
| Jun 5, 2026 | Krishnan Suma | director, 10 percent owner, officer: President, R&D | Sell | 25,000 | $308.11 | $7.70M | 1,402,835 |
| Jun 5, 2026 | Krishnan Krish S | director, 10 percent owner, officer: President and CEO | Sell | 25,000 | $308.12 | $7.70M | 1,474,933 |
| May 27, 2026 | Thomas John Charles | officer: EVP, General Counsel | Sell | 642 | $302.03 | $193.9K | 0Exit |
| Mar 6, 2026 | Krishnan Krish S | director, 10 percent owner, officer: President and CEO | Sell | 25,000 | $263.17 | $6.58M | 1,499,770 |
| Mar 6, 2026 | Krishnan Suma | director, 10 percent owner, officer: President, R&D | Sell | 25,000 | $263.21 | $6.58M | 1,427,748 |
| Feb 26, 2026 | JANNEY DANIEL | director | Sell | 60,161 | $268.44 | $16.15M | 107,300-36% |
| Feb 23, 2026 | ROSSI DINO A | director | Sell | 8,116 | $260.49 | $2.11M | 89,525 |
| Feb 19, 2026 | ROSSI DINO A | Director | Sell | 18,950 | $261.41 | $4.95M | 0 |
| Feb 11, 2026 | ROMANO KATHRYN | officer: Chief Accounting Officer | Sell | 12,500 | $272.14 | $3.40M | 29,818-30% |
| Dec 5, 2025 | Krishnan Krish S | President and CEO | Sell | 5,693 | $219.55 | $1.25M | 1,496,886 |
| Dec 5, 2025 | Krishnan Suma | President, R&D | Sell | 50,000 | $220.15 | $11.01M | 1,507,100 |
| Jul 16, 2025 | Krishnan Suma | President, R&D | Sell | 35,873 | $150.39 | $5.39M | 1,512,529 |
| Jul 11, 2025 | Krishnan Suma | President, R&D | Sell | 13,827 | $150.24 | $2.08M | 1,532,856 |
| Mar 13, 2025 | Krishnan Suma | President, R&D | Sell | 50,000 | $177.79 | $8.89M | 1,556,956 |
| Feb 28, 2025 | ROMANO KATHRYN | Chief Accounting Officer | Sell | 750 | $175.22 | $131.4K | 12,604 |
| Dec 13, 2024 | Krishnan Suma | President, R&D | Sell | 50,000 | $164.80 | $8.24M | 1,555,960 |
| Sep 13, 2024 | Krishnan Suma | President, R&D | Sell | 50,000 | $197.77 | $9.89M | 1,583,305 |
| Jun 11, 2024 | Krishnan Suma | President, R&D | Sell | 50,000 | $175.76 | $8.79M | 1,611,162 |
| May 22, 2024 | Gangolli Julian S | Director | Sell | 20,000 | $164.13 | $3.28M | 9,070-69% |
| Mar 11, 2024 | Krishnan Suma | President, R&D | Sell | 50,000 | $170.95 | $8.55M | 1,635,116 |
| Mar 1, 2024 | ROMANO KATHRYN | Chief Accounting Officer | Sell | 12,200 | $165.94 | $2.02M | 12,936-49% |
| Feb 28, 2024 | ROMANO KATHRYN | Chief Accounting Officer | Sell | 8,087 | $136.91 | $1.11M | 12,556-39% |
| Jan 24, 2024 | Romano Kathryn | Chief Accounting Officer | Sell | 2,500 | $130.00 | $325.0K | 12,556 |
| Dec 12, 2023 | Krishnan Suma | President, R&D | Sell | 49,900 | $105.66 | $5.27M | 1,654,938 |
| Sep 12, 2023 | Krishnan Suma | President, R&D | Sell | 39,443 | $126.93 | $5.01M | 1,679,330 |
| Jun 9, 2023 | JANNEY DANIEL | Director | Sell | 50,000 | $128.36 | $6.42M | 152,758 |
| Jun 9, 2023 | ORTH ANDREW C. | Chief Commercial Officer | Sell | 12,500 | $128.61 | $1.61M | 7,339-63% |
| Jun 2, 2023 | Krishnan Suma | President, R&D | Sell | 50,000 | $116.20 | $5.81M | 1,690,454 |
| May 23, 2023 | JANNEY DANIEL | Director | Sell | 50,000 | $95.02 | $4.75M | 157,362 |
| May 23, 2023 | Romano Kathryn | Chief Accounting Officer | Sell | 53,428 | $101.60 | $5.43M | 15,984-77% |
| May 11, 2023 | JANNEY DANIEL | Director | Sell | 17,100 | $90.74 | $1.55M | 207,362 |
| Apr 21, 2023 | JANNEY DANIEL | Director | Sell | 7,900 | $90.32 | $713.5K | 224,462 |
| Apr 18, 2023 | Krishnan Krish S | President and CEO | Sell | 39,776 | $87.44 | $3.48M | 1,733,288 |
| Apr 18, 2023 | Krishnan Suma | President, R&D | Sell | 39,776 | $87.44 | $3.48M | 1,737,638 |
| Mar 2, 2023 | ROSSI DINO A | Director | Sell | 40,000 | $83.25 | $3.33M | 83,691-32% |
| Jan 19, 2023 | Krishnan Suma | President, R&D | Sell | 29,383 | $80.86 | $2.38M | 1,741,885 |
| Jan 5, 2023 | Krishnan Suma | President, R&D | Sell | 7,686 | $80.08 | $615.5K | 1,763,688 |
| Jan 3, 2023 | Krishnan Suma | President, R&D | Sell | 19,422 | $80.34 | $1.56M | 1,769,699 |
| Dec 20, 2022 | Krishnan Suma | President, R&D | Sell | 21,099 | $80.10 | $1.69M | 1,777,146 |
| Nov 28, 2022 | Krishnan Suma | President, R&D | Sell | 4 | $80.01 | $320.04 | 1,787,718 |
| Nov 10, 2022 | Krishnan Suma | President, R&D | Sell | 1,789 | $80.05 | $143.2K | 1,787,722 |
| Aug 9, 2022 | Krishnan Suma | President, R&D | Sell | 50,000 | $81.18 | $4.06M | 1,804,600 |
| Dec 14, 2021 | JANNEY DANIEL | Director | Sell | 100,000 | $70.50 | $7.05M | 266,362-27% |
| Dec 14, 2021 | Krishnan Suma | Chief Operating Officer | Sell | 100,000 | $70.50 | $7.05M | 50,000-67% |
KRYS Insider Buying Activity
The following table shows recent insider purchases of Krystal Biotech, Inc. (KRYS) stock reported via SEC Form 4 filings.
No insider buying activity found for KRYS in the last 12 months.
KRYS Insider Selling Activity
The following table shows recent insider sales of Krystal Biotech, Inc. (KRYS) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Sep 4, 2026 | Krishnan Suma | director, 10 percent owner, officer: President, R&D | Sell | 25,000 | $359.32 | $8.98M | 1,326,625 |
| Sep 4, 2026 | Krishnan Krish S | director, 10 percent owner, officer: President and CEO | Sell | 25,000 | $359.32 | $8.98M | 1,372,023 |
| Aug 14, 2026 | ROSSI DINO A | director | Sell | 25,000 | $329.12 | $8.23M | 74,659-25% |
| Jun 26, 2026 | Thomas John Charles | officer: EVP, General Counsel | Sell | 1,000 | $347.27 | $347.3K | 0Exit |
| Jun 5, 2026 | Krishnan Suma | director, 10 percent owner, officer: President, R&D | Sell | 25,000 | $308.11 | $7.70M | 1,402,835 |
| Jun 5, 2026 | Krishnan Krish S | director, 10 percent owner, officer: President and CEO | Sell | 25,000 | $308.12 | $7.70M | 1,474,933 |
| May 27, 2026 | Thomas John Charles | officer: EVP, General Counsel | Sell | 642 | $302.03 | $193.9K | 0Exit |
| Mar 6, 2026 | Krishnan Krish S | director, 10 percent owner, officer: President and CEO | Sell | 25,000 | $263.17 | $6.58M | 1,499,770 |
| Mar 6, 2026 | Krishnan Suma | director, 10 percent owner, officer: President, R&D | Sell | 25,000 | $263.21 | $6.58M | 1,427,748 |
| Feb 26, 2026 | JANNEY DANIEL | director | Sell | 60,161 | $268.44 | $16.15M | 107,300-36% |
| Feb 23, 2026 | ROSSI DINO A | director | Sell | 8,116 | $260.49 | $2.11M | 89,525 |
| Feb 19, 2026 | ROSSI DINO A | Director | Sell | 18,950 | $261.41 | $4.95M | 0 |
| Feb 11, 2026 | ROMANO KATHRYN | officer: Chief Accounting Officer | Sell | 12,500 | $272.14 | $3.40M | 29,818-30% |
| Dec 5, 2025 | Krishnan Krish S | President and CEO | Sell | 5,693 | $219.55 | $1.25M | 1,496,886 |
| Dec 5, 2025 | Krishnan Suma | President, R&D | Sell | 50,000 | $220.15 | $11.01M | 1,507,100 |
| Jul 16, 2025 | Krishnan Suma | President, R&D | Sell | 35,873 | $150.39 | $5.39M | 1,512,529 |
| Jul 11, 2025 | Krishnan Suma | President, R&D | Sell | 13,827 | $150.24 | $2.08M | 1,532,856 |
| Mar 13, 2025 | Krishnan Suma | President, R&D | Sell | 50,000 | $177.79 | $8.89M | 1,556,956 |
| Feb 28, 2025 | ROMANO KATHRYN | Chief Accounting Officer | Sell | 750 | $175.22 | $131.4K | 12,604 |
| Dec 13, 2024 | Krishnan Suma | President, R&D | Sell | 50,000 | $164.80 | $8.24M | 1,555,960 |
| Sep 13, 2024 | Krishnan Suma | President, R&D | Sell | 50,000 | $197.77 | $9.89M | 1,583,305 |
| Jun 11, 2024 | Krishnan Suma | President, R&D | Sell | 50,000 | $175.76 | $8.79M | 1,611,162 |
| May 22, 2024 | Gangolli Julian S | Director | Sell | 20,000 | $164.13 | $3.28M | 9,070-69% |
| Mar 11, 2024 | Krishnan Suma | President, R&D | Sell | 50,000 | $170.95 | $8.55M | 1,635,116 |
| Mar 1, 2024 | ROMANO KATHRYN | Chief Accounting Officer | Sell | 12,200 | $165.94 | $2.02M | 12,936-49% |
| Feb 28, 2024 | ROMANO KATHRYN | Chief Accounting Officer | Sell | 8,087 | $136.91 | $1.11M | 12,556-39% |
| Jan 24, 2024 | Romano Kathryn | Chief Accounting Officer | Sell | 2,500 | $130.00 | $325.0K | 12,556 |
| Dec 12, 2023 | Krishnan Suma | President, R&D | Sell | 49,900 | $105.66 | $5.27M | 1,654,938 |
| Sep 12, 2023 | Krishnan Suma | President, R&D | Sell | 39,443 | $126.93 | $5.01M | 1,679,330 |
| Jun 9, 2023 | JANNEY DANIEL | Director | Sell | 50,000 | $128.36 | $6.42M | 152,758 |
| Jun 9, 2023 | ORTH ANDREW C. | Chief Commercial Officer | Sell | 12,500 | $128.61 | $1.61M | 7,339-63% |
| Jun 2, 2023 | Krishnan Suma | President, R&D | Sell | 50,000 | $116.20 | $5.81M | 1,690,454 |
| May 23, 2023 | JANNEY DANIEL | Director | Sell | 50,000 | $95.02 | $4.75M | 157,362 |
| May 23, 2023 | Romano Kathryn | Chief Accounting Officer | Sell | 53,428 | $101.60 | $5.43M | 15,984-77% |
| May 11, 2023 | JANNEY DANIEL | Director | Sell | 17,100 | $90.74 | $1.55M | 207,362 |
| Apr 21, 2023 | JANNEY DANIEL | Director | Sell | 7,900 | $90.32 | $713.5K | 224,462 |
| Apr 18, 2023 | Krishnan Krish S | President and CEO | Sell | 39,776 | $87.44 | $3.48M | 1,733,288 |
| Apr 18, 2023 | Krishnan Suma | President, R&D | Sell | 39,776 | $87.44 | $3.48M | 1,737,638 |
| Mar 2, 2023 | ROSSI DINO A | Director | Sell | 40,000 | $83.25 | $3.33M | 83,691-32% |
| Jan 19, 2023 | Krishnan Suma | President, R&D | Sell | 29,383 | $80.86 | $2.38M | 1,741,885 |
| Jan 5, 2023 | Krishnan Suma | President, R&D | Sell | 7,686 | $80.08 | $615.5K | 1,763,688 |
| Jan 3, 2023 | Krishnan Suma | President, R&D | Sell | 19,422 | $80.34 | $1.56M | 1,769,699 |
| Dec 20, 2022 | Krishnan Suma | President, R&D | Sell | 21,099 | $80.10 | $1.69M | 1,777,146 |
| Nov 28, 2022 | Krishnan Suma | President, R&D | Sell | 4 | $80.01 | $320.04 | 1,787,718 |
| Nov 10, 2022 | Krishnan Suma | President, R&D | Sell | 1,789 | $80.05 | $143.2K | 1,787,722 |
| Aug 9, 2022 | Krishnan Suma | President, R&D | Sell | 50,000 | $81.18 | $4.06M | 1,804,600 |
| Dec 14, 2021 | JANNEY DANIEL | Director | Sell | 100,000 | $70.50 | $7.05M | 266,362-27% |
| Dec 14, 2021 | Krishnan Suma | Chief Operating Officer | Sell | 100,000 | $70.50 | $7.05M | 50,000-67% |
KRYS Insiders
Similar Stocks to KRYS
VRTX
Vertex Pharmaceuticals Incorporated
$509.95-1.24%
$131.05B
REGN
Regeneron Pharmaceuticals, Inc.
$787.99-0.16%
$81.33B
MRNA
Moderna, Inc.
$154.04-2.43%
$61.12B
RVMD
Revolution Medicines, Inc.
$189.02-4.02%
$41.87B
INSM
Insmed Incorporated
$120.00-3.14%
$26.01B
INCY
Incyte Corporation
$125.31-1.30%
$25.40B
UTHR
United Therapeutics Corporation
$494.63-0.51%
$21.00B
NBIX
Neurocrine Biosciences, Inc.
$147.50-2.85%
$15.71B